400-1022-688
Infectious disease diagnosis

SARS-CoV-2 Neutralizing antibody Rapid Test (TRFIA)Kit

(TRFIA)

INTENDED USE

The PocRoc® SARS-CoV-2 Neutralizing Antibody Rapid Test Kit is developed for in vitro qualitative detection of SARS-CoV-2 neutralizing antibodies in human serum, plasma or whole blood samples. SARS-CoV-2 Neutralizing antibody is an important marker for assessing the effectiveness of the SARS-CoV-2 vaccines. The reagent is for neutralizing antibody detection in samples from individuals after vaccine injection or recovered from COVID-19. PocRoc® SARS-CoV-2 Neutralizing Antibody Rapid Test Kit has great significance for the development of SARS-CoV-2 vaccines, evaluation of effectiveness, and evaluation of neutralizing antibody levels in human bodies. 

For Medical Professional Use Only!




Top

Earlier
Mar. 2014

CFDA approvals for five immunoassay reagents adaptable to most chemical analyzers were obtained

Feb. 2014

CFDA approvals for time-resolved fluorescence immunochromatographic analyzer were obtained

Sep. 2013

Lumigenex passed The first Food and Drug Administration by the Suzhou Municipal Quality Management System Assessment